2026-01-20 - Analysis Report
**Report for Thermo Fisher (TMO) Stock Analysis**

### Company Overview
Thermo Fisher Scientific is a leading biotechnology company specializing in laboratory equipment and analytical instruments.

### Return Rate Comparison

* Cumulative Return of TMO: 41.38%
* Cumulative Return of S&P 500 (VOO): 93.30%
* Divergence: -51.90 (relative divergence: 14.30%)

The cumulative return of TMO lags behind the S&P 500 by -51.90% at the end of the data period, indicating a lower return rate.

### Alpha, Beta Analysis

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 21.0% | 17.1% | 16.0% | 1.1  | 84.1B  |
| 2017-2019  | 46.0% | 17.1% | 29.0% | 1.1  | 122.1B |
| 2018-2020  | 22.0% | 17.1% | 1.0%  | 0.8  | 175.0B  |
| 2019-2021  | 77.0% | 15.0% | 34.0% | 0.8  | 250.7B  |
| 2020-2022  | 8.0%  | 25.4% | 10.0% | 0.8  | 206.9B  |
| 2021-2023  | -30.0% | 28.6% | -31.0% | 0.9  | 199.4B  |
| 2022-2024  | -37.0% | 24.4% | -57.0% | 0.9  | 195.4B  |
| 2023-2025  | -17.0% | 27.2% | -79.0% | 0.8  | 217.7B  |

The alpha values indicate the excess return of TMO relative to the S&P 500, while the beta values show the sensitivity of TMO to market fluctuations.

### Recent Stock Price Fluctuations

* Close: $618.72
* Last-market: -$0.95 (from previous close)
* 5-day SMA: $617.55
* 20-day SMA: $597.42
* 60-day SMA: $581.89

The stock price has declined in recent days, with the 5-day SMA slightly above the current price. The 20-day SMA and 60-day SMA are below the current price, indicating a bearish trend.

### RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence

* Market Risk Indicator (MRI): 0.80 (Medium Investment)
* RSI: 66.79
* PPO: 0.30
* Hybrid Signal: Buy (Cash 0%)
* Recent (20 days) relative divergence change: +0.60 (improving)
* 7-day Rank change: +65 (rank up)
* 7-day Dynamic Expected Return change: +10.20 (improving)
* Expected Return (%): -43.90%

The RSI and PPO indicators suggest a moderate risk level, while the hybrid signal indicates a buy signal. The expected return is negative, indicating a potential decline in stock price.

### Recent News & Significant Events

* [2026-01-06] Will Thermo Fisher (TMO) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
* [2026-01-06] Here's How Much You'd Have If You Invested $1000 in Thermo Fisher Scientific a Decade Ago - Nasdaq
* [2026-01-17] Thermo Fisher Scientific (TMO) Valuation After Leadership Shakeup And New AI Lab Partnerships - simplywall.st
* [2026-01-14] Should You Continue to Hold Thermo Fisher Stock in Your Portfolio Now? - TradingView
* [2025-12-11] What Is Happening With Thermo Fisher Scientific Stock? - Trefis
* [2025-11-22] Thermo Fisher Scientific Stock Prediction: Where Analysts See the Stock Going by 2027 - TIKR.com

### Analyst Opinions

 Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.54 (~Buy)
- Opinions: 23
- Target Price (avg/high/low): 651.52 / 750.00 / 575.00

The analyst consensus is buy, with a target price range of $651.52 to $750.00.

### Recent Earnings Analysis

| Date | EPS | Revenue |
|-----|----|---------|
| 2025-10-31 | 4.28 | $11.12B |
| 2025-08-01 | 4.28 | $10.86B |
| 2025-05-02 | 3.99 | $10.36B |
| 2024-11-01 | 4.26 | $10.60B |
| 2025-10-31 | 4.26 | $10.60B |

The earnings per share (EPS) has been consistently high, while the revenue has shown a slight decline in recent periods.

### Financial Information

#### Revenue and Profitability

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $11.12B | 41.21% |
| 2025-06-30 | $10.85B | 40.61% |
| 2025-03-31 | $10.36B | 40.86% |
| 2024-12-31 | $11.39B | 42.32% |
| 2024-09-30 | $10.60B | 40.84% |

#### Capital and Profitability

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $51.02B | 3.17% |
| 2025-06-30 | $50.51B | 3.20% |
| 2025-03-31 | $49.39B | 3.05% |
| 2024-12-31 | $49.59B | 3.69% |
| 2024-09-30 | $48.99B | 3.33% |

The revenue and profit margin have shown a slight decline in recent periods, while the equity and return on equity (ROE) have been consistent.

### Comprehensive Analysis

Thermo Fisher has a lower return rate compared to the S&P 500, with a cumulative return of 41.38% compared to 93.30%. The alpha values indicate a moderate excess return, while the beta values show a high sensitivity to market fluctuations. The RSI and PPO indicators suggest a moderate risk level, while the hybrid signal indicates a buy signal. The expected return is negative, indicating a potential decline in stock price. Overall, the financial performance has been steady, but the stock price has declined in recent days.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.